Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor

This publication has 32 references indexed in Scilit:

• Studies on Prostatic Cancer: I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate
  Journal of Urology, 2002
• The human prostatic cancer cell line LNCaP and its derived sublines: An in vitro model for the study of androgen sensitivity
  The Journal of Steroid Biochemistry and Molecular Biology, 1991
• Synergistic Activity of Suramin With Tumor Necrosis Factor and Doxorubicin on Human Prostate Cancer Cell Lines
  JNCI Journal of the National Cancer Institute, 1990
• Production of epidermal growth factor and transforming growth factor‐α by the androgen‐responsive LNCaP human prostate cancer cell line
  The Prostate, 1990
• Application of the MTT assay to human prostate cancer cell lines in vitro: Establishment of test conditions and assessment of hormone‐stimulated growth and drug‐induced cytostatic and cytotoxic effects
  The Prostate, 1988
• Androgen‐dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP
  The Prostate, 1986
• Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP‐r
  The Prostate, 1985
• Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice
  International Journal of Cancer, 1984
• Treatment of Advanced Prostatic Carcinoma with Estramustine Phosphate (Estracyt®)
  Scandinavian Journal of Urology and Nephrology, 1977
• Methyltrienolone, a specific ligand for cellular androgen receptors
  Steroids, 1975